Home Page
-
Novel compounds open new research avenues for Alzheimer’s disease therapeutics
Two new compounds developed at the Vanderbilt University Warren Center for Neuroscience Drug Discovery will enable research into a protein family with ties to Alzheimer’s disease, setting the stage for the development of a different kind of therapeutic than is currently available. Read MoreFeb. 24, 2026
-
Anti-Marburg antibody from Vanderbilt Health sent to Ethiopia during outbreak
MBP091, an investigational, anti-Marburg virus antibody identified by Vanderbilt Health researchers and under development by San Diego-based Mapp Biopharmaceutical Inc., was provided to Ethiopian health officials during that country’s first outbreak of the deadly viral infection late last year. Read MoreFeb. 19, 2026
-
Katrin Karbstein named vice chair of biochemistry
Katrin Karbstein, the co-leader of the Cancer Cell Biology Research Program in the Vanderbilt-Ingram Cancer Center, will now expand her focus to support her department’s mission across research, service, and education, with a special focus on faculty affairs. Read MoreFeb. 19, 2026
-
Novel vaccine protects against C. diff disease and recurrence
New study from Borden Lacy and Audrey Thomas represents a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection. Read MoreFeb. 18, 2026
-
Study challenges traditional assumptions about gut inflammation and Crohn’s disease
A new study reveals mechanistic underpinnings of Crohn’s disease, including some vulnerabilities within the ascending colon. This work challenges the assumption that all regions of the gut respond similarly to inflammation, argues for region-specific treatments for the disease, and highlights a potential new target for treatment within the ascending colon. Read MoreFeb. 18, 2026
-
Neuroscientist Shan Meltzer named 2026 Sloan Research Fellow
Shan Meltzer was named a Sloan Research Fellow, one of the most competitive honors available to young investigators, for her research into how the neural circuits responsible for touch and pain processing are built and organized. Read MoreFeb. 17, 2026
-
Targeting immune suppression to overcome melanoma resistance
Ann Richmond outlines a promising therapeutic strategy that may re-sensitize treatment-resistant tumors to immunotherapy. The research introduces a three-drug combination that enhances immune activity and suppresses tumor-promoting immune cells. Read MoreFeb. 16, 2026
-
Nakagawa to deliver inaugural Kairos Lecture on Feb. 26
Dr. Teru Nakagawa, professor of molecular physiology and biophysics in the School of Medicine Basic Sciences, will deliver the inaugural Kairos Lecture on Thursday, Feb. 26, 2026. Read MoreFeb. 15, 2026
-
Celebrating love found
Whether they met at the bench or bonded over research setbacks, these alums prove that meaningful relationships can flourish alongside rigorous scientific training. In honor of Valentine’s Day, we asked them to share how they did it. Read MoreFeb. 12, 2026
-
Introducing the School of Medicine Basic Sciences Kairos Lecture Series
The School of Medicine Basic Sciences is launching a new lecture series: “The Kairos Lectures: Research of Consequence at the Right Moment.” Read MoreFeb. 12, 2026